| NCT07007637 | A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa | ENROLLING_BY_INVITATION | PHASE3 | 2025-06-27 | 2028-06-13 | 2028-06-13 |
| NCT06994936 | An Open-label Study in Healthy Adults to Evaluate the Relative Bioequivalence of a Single-dose Administration of Sonelokimab Either by a Prefilled Syringe or an Autoinjector | ACTIVE_NOT_RECRUITING | PHASE1 | 2025-06-05 | 2025-10-16 | 2025-10-16 |
| NCT06768671 | An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN) | RECRUITING | PHASE3 | 2024-12-30 | 2026-03-27 | 2026-03-27 |
| NCT06641076 | Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug | RECRUITING | PHASE3 | 2024-10-15 | 2027-01-15 | 2027-01-15 |
| NCT06641089 | Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response | RECRUITING | PHASE3 | 2024-10-15 | 2027-01-15 | 2027-01-15 |
| NCT06411899 | A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa | ACTIVE_NOT_RECRUITING | PHASE3 | 2024-05-15 | 2026-06-17 | 2025-06-17 |
| NCT06411379 | Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa | ACTIVE_NOT_RECRUITING | PHASE3 | 2024-05-14 | 2026-06-17 | 2025-06-17 |
| NCT05640245 | Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis | COMPLETED | PHASE2 | 2022-12-13 | 2024-01-15 | 2023-09-05 |
| NCT05322473 | Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa | COMPLETED | PHASE2 | 2022-04-25 | 2023-08-30 | 2023-05-09 |